| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |